OSI-930
25 mg
| 99.76%
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
OSI-930
10 mg
| 99.76%
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol
TargetMol
TargetMol
TargetMol
TargetMol
OSI-930
50 mg
| 99.76%
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol
OSI-930, an orally active inhibitor of c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2), targets cancer cell proliferation and blood vessel growth (angiogenesis) in tumors.
More Information
Supplier Page
TargetMol